Pharma in 2014: Deals worth billions and fines worth millions

Even as private firms were busy stitching merger and partnership deals, the government also remained active during the year working on a separate policy to promote and strengthen domestic......

Pharma firms spend 10% of production cost on tie-ups

Leading pharmaceutical companies are now making serious attempts to tie up with technology partners to enable their consumers identify genuine products in the market. Drug makers such as Ranbaxy......

Taxpayers' right to be taxed the least

There are so many exemptions that one sometimes finds overlapping exemptions and two exemptions for the same item with slightly different nomenclature and conditions, says Sukumar Mukhopadhyay. The......

Drug patent settlements to come under EU scanner

Patent settlements between pharmaceutical companies that make original drugs and their generic manufacturing rivals are to come under renewed scrutiny from the European Union's competition......